BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 28, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 29, 2010
View Archived Issues
ODE-(S)-HPMPA and ODE-(S)-HPMPC inhibit HIV replication by new mode of action
Read More
Interim analysis of SENSE trial data shows superior safety of etravirine vs. efavirenz in HIV
Read More
AKN-028 significantly alters gene expression profiles of AML cells
Read More
PI3K-alpha inhibitor PIK-75 induces apoptosis of AML cells
Read More
Boehringer Ingelheim claims new inhibitors of LFA-1A/ICAM-1 interaction
Read More
New inhibitors of insulin-like growth factor 1 receptor presented
Read More
Novel antagonists discovered of proteinase-activated PAR1 receptor
Read More
Exelixis divulges novel mTORC1 inhibitors
Read More
AstraZeneca identifies novel antibacterial agents
Read More
Telapristone shows promise in preclinical models of breast cancer
Read More
Mitsubishi Tanabe out-licenses bepotastine to Dong-A Pharma for ophthalmic use in Korea
Read More
Icagen and Pfizer advance phase I trial of voltage-gated Na(V)1.7 sodium channel inhibitor
Read More
FDA requires additional time to review Afrezza NDA
Read More
Mesoblast acquires Angioblast Systems
Read More
Nordic Pharma collaborates with Nippon Kayaku on Spanidin
Read More
ReNeuron advances phase I trial of ReN-001 stem cell therapy
Read More
Bill & Melinda Gates Foundation provides grant to TB Alliance
Read More
Santarus and Pharming submit BLA to FDA for Rhucin
Read More
Sinovac receives SFDA approval to begin trials of EV-71 vaccine
Read More
PharmaGap and Queen's University collaborate to develop GAP-107B8 for bladder cancer
Read More
Santen files IND application with FDA for Clinical Data's ATL-313 in glaucoma
Read More
ExonHit Therapeutics receives grants for AclarusDx and EHT-107 programs
Read More
Mitsubishi Tanabe submits application to market FTY-720 in Japan for MS
Read More
Shionogi and AnGes to codevelop NFkB decoy oligo
Read More
BioSante raises funds to support phase III LibiGel program
Read More
